INDIVIOR PHARMACEUTICALS, INC. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
M-Score (Beneish; >-1.78 flags risk)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
EPS (Diluted)
$2
Book Value Per Share
$-1
Free Cash Flow Per Share
$-1
Cash Per Share
$2
Revenue Per Share
$10
OCF Per Share
$-0
Return on Equity
-96.6%
Return on Assets
16.7%
Return on Invested Capital
270.8%
Debt to Equity
-2.96
Current Ratio
0.71
Quick Ratio
0.55
Asset Turnover
0.98
Days Sales Outstanding
74.53
Days Payables Outstanding
71.22
Days Inventory On Hand
227.01
Cash Conversion Cycle
230.32
R&D / Revenue
7.8%
SBC / Revenue
2.1%
Capex / Revenue
5.3%
Working Capital
$-262M
Net Current Asset Value
$-648M
Invested Capital
$192M
OCF / Net Income
-0.13
FCF / Net Income
-0.44
Accruals Ratio (Sloan)
19.7%
Net Debt
$95M
Net Debt / EBITDA
0.35
Interest Coverage
6.89
Cash Coverage
-0.71
Capex Coverage
-0.41
Tangible Common Equity
$-100M
TCE / Total Assets
-8.3%
Goodwill / Total Assets
0.2%
NOPAT
$230M
Cash ROIC
-109.4%
WC / Revenue
-21.1%
Capex / D&A
6.60
Reinvestment Rate
21.4%
Total Payout Ratio
5.2%
Asset Growth vs Revenue Growth
-13.0%
Stock Price (FY-end)
$36
Market Cap
$4.59B
P/E Ratio
21.87
P/S Ratio
3.71
P/OCF Ratio
45.92
P/FCF Ratio
236.17
Enterprise Value
$4.69B
EV / EBITDA
17.23
EV / Sales
3.78
EV / FCF
235.46
FCF Yield
-2.0%
Shareholder Yield
-0.3%
Buyback Yield
0.2%
R&D Yield
2.1%
Capex Yield
1.4%
Operating Leverage
137.31
Shares Variation (YoY)
-3.8%
Beta (5Y)
-0.14
Cost of Equity
3.8%
Cost of Debt (after tax)
11.5%
WACC
4.3%
ROIC - WACC Spread
266.6%
52W High
$37
52W Low
$8
Trailing Return 1Y
189.8%
Trailing Return 5Y
447.8%
F-Score (Piotroski)
4.00
M-Score (Beneish)
-1.39
Z-Score (Altman)
3.33
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.